Activation or anergy: NKT cells are stunned by α-galactosylceramide

Por Sullivan, Barbara A., Kronenberg, Mitchell
Publicado em 2005

Co-receptor choice by Vα14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection

Por Engel, Isaac, Hammond, Kirsten, Sullivan, Barbara A., He, Xi, Taniuchi, Ichiro, Kappes, Dietmar, Kronenberg, Mitchell
Publicado em 2010

Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d

Por Wu, Douglass, Zajonc, Dirk M., Fujio, Masakazu, Sullivan, Barbara A., Kinjo, Yuki, Kronenberg, Mitchell, Wilson, Ian A., Wong, Chi-Huey
Publicado em 2006

Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14i NKT cells

Por Sullivan, Barbara A., Nagarajan, Niranjana A., Wingender, Gerhard, Wang, Jing, Scott, Iain, Tsuji, Moriya, Franck, Richard W., Porcelli, Steven, Zajonc, Dirk, Kronenberg, Mitchell
Publicado em 2009

A CD1d-Dependent Antagonist Inhibits the Activation of Invariant NKT Cells and Prevents Development of Allergen-Induced Airway Hyperreactivity

Por Lombardi, Vincent, Stock, Philippe, Singh, Abinav K., Kerzerho, Jerome, Yang, Wen, Sullivan, Barbara A., Li, Xiangming, Shiratsuchi, Takayuki, Hnatiuk, Nathan E., Howell, Amy R., Yu, Karl O. A., Porcelli, Steven A., Tsuji, Moriya, Kronenberg, Mitchell, Wilson, S. Brian, Akbari, Omid
Publicado em 2010

Clinical pharmacology of AMG 181, a gut-specific human anti-α(4)β(7) monoclonal antibody, for treating inflammatory bowel diseases

Por Pan, Wei-Jian, Köck, Kathleen, Rees, William A, Sullivan, Barbara A, Evangelista, Christine M, Yen, Mark, Andrews, Jane M, Radford-Smith, Graham L, Prince, Peter J, Reynhardt, Kaz O, Doherty, David R, Patel, Sonal K, Krill, Christine D, Zhou, Kefei, Shen, Jing, Smith, Lynn E, Gow, Jason M, Lee, Jonathan, Treacy, Anthony M, Yu, Zhigang, Platt, Virginia M, Borie, Dominic C
Publicado no Br J Clin Pharmacol (2014)